Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
US Speciality Formulations Invests US$15 million to Expand its Biopharma Facility in USA
US Speciality Formulations USSF invests US$15 million to expand its Lehigh Valley biopharma facility in USA The expansion will introduce new clean room suites and advanced automated packaging and product inspection equipment
The University of Chicago Opens New Manufacturing Facility in USA
The University of Chicago is set to open a new manufacturing facility in the USA The new manufacturing facility is equipped for bacterial manufacturing in an anaerobic environment, supporting fermentation, lyophilisation, and encapsulation of live biotherapeutic products
BeiGene Invests US$800 million to Construct New R & D facility in China
BeiGene is investing US$800 million in constructing a new research and development RD facility in China The new facility features stateoftheart biologics manufacturing capabilities along with a clinical research and development centre
The University of Queensland plans to Open a Lab in Australia
The University of Queensland plans to open a new UQ lab to develop personalised cancer vaccines in Australia This stateoftheart lab will consolidate the necessary equipment and expertise to design,
CordenPharma Invests US$981 million (€900 mn) to Expand in USA & Europe
CordenPharma is investing US$981 million 900 million to expand its peptide platform at its sites in USA, and Europe The expansions, which encompass both enhancements to existing facilities
LOTTE Biologics Invests US$3.5 billion (₩4.6T) to Open New Bio Campus in Korea
LOTTE Biologics is investing US$35 billion 46 trillion to construct a new Bio Campus in Songdo, Incheon, Korea This stateoftheart facility, covering an impressive
Vetter Expands Manufacturing Sites in USA and Germany
Vetter intends to relocate and expand its development services site from Skokie to Des Plaines, Illinois, bolstering its US presence The project also includes investments in commercial operations
SGS North America Expands Biologics Testing Capabilities in USA
SGS North America has expanded its capacity and capabilities to enhance biologics testing services in the USA The 60,000 squarefoot, stateoftheart facility in Lincolnshire
Bora Pharmaceuticals Expands Sterile Manufacturing Facility in Maryland, USA
Bora Pharmaceuticals plans for the expansion of sterile manufacturing facility in Maryland, USA to provide Sterile FillFinish Services The newly acquired 87,000
Novo Nordisk Invests US$4.1 billion to Expand Production Capacity in USA
Novo Nordisk plans to invest U$41 billion towards constructing a second fill and finish manufacturing facility in the USA The expansion project will increase production capacity significantly
